CEO Congleton Acquires 24,082 Of Mineralys Therapeutics Inc [MLYS]

Reuters
2025.11.24 22:08
portai
I'm PortAI, I can summarize articles.

Congleton Jon Chief Executive Officer of Mineralys Therapeutics Inc [MLYS] filed a Form 4 on November 24, 2025 with the Securities and Exchange Commission disclosing the following changes in ownership:Date11/21/25TransactionExercise(1) Shares24,082Price$0.54Value$13,004Ending Holdings: 655,387 - Direct(1) Exercised 5.3 years before expiration date.For a free trial, or to learn more about our insider trading analysis and data services, please visit or contact us at (301) 913-5100 or send an email to info@washingtonservice.com.Founded in 1970, The Washington Service provides securities professionals with financial, economic and public policy research and data.

Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer